1. Fiuza-Luces, C. et al. Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors. Nat. Rev. Cardiol. 15, 731–743 (2018).

2. Lee, I.-M. Physical activity and cancer prevention — data from epidemiologic studies. Med. Sci. Sports Exerc. 35, 1823–1827 (2003).

3. O’Keefe, J. H. et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin. Proc. 87, 587–595 (2012).

4. Rao, P., Hutter, A. M. & Baggish, A. L. The limits of cardiac performance: can too much exercise damage the heart? Am. J. Med. 131, 1279–1284 (2018).

5. Levine, B. D. Can intensive exercise harm the heart? The benefits of competitive endurance training for cardiovascular structure and function. Circulation 130, 987–991 (2014).

6. Eijsvogels, T. M. H., Fernandez, A. B. & Thompson, P. D. Are there deleterious cardiac effects of acute and chronic endurance exercise? Physiol. Rev. 96, 99–125 (2016).

7. Morris, J. N., Heady, J. A., Raffle, P. A., Roberts, C. G. & Parks, J. W. Coronary heart-disease and physical activity of work. Lancet 265, 1111–1120 (1953).

8. Pedisic, Z. et al. Is running associated with a lower risk of all-cause, cardiovascular and cancer mortality, and is the more the better? A systematic review and meta-analysis. Br. J. Sports Med. https://doi.org/10.1136/bjsports-2018-100493 (2019).

9. Nocon, M. et al. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur. J. Cardiovasc. Prev. Rehabil. 15, 239–246 (2008).

10. Ekelund, U. et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ 366, l4570 (2019).

11. Wen, C. P. et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 378, 1244–1253 (2011).

12. Williams, C. J. et al. Genes to predict VO 2max trainability: a systematic review. BMC Genomics 18, 831 (2017).

13. Skinner, J. S. et al. Age, sex, race, initial fitness, and response to training: the HERITAGE Family Study. J. Appl. Physiol. 90, 1770–1776 (2001).

14. Roberts, M. A., O’Dea, J., Boyce, A. & Mannix, E. T. Fitness levels of firefighter recruits before and after a supervised exercise training program. J. Strength. Cond. Res. 16, 271–277 (2002).

15. Mandsager, K. et al. Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Netw. Open 1, e183605 (2018).

16. Tanasescu, M. et al. Exercise type and intensity in relation to coronary heart disease in men. JAMA 288, 1994–2000 (2002).

17. Mora, S., Cook, N., Buring, J. E., Ridker, P. M. & Lee, I.-M. Physical activity and reduced risk of cardiovascular events. Circulation 116, 2110–2118 (2007).

18. Kokkinos, P. et al. Exercise capacity and mortality in older men: a 20-year follow-up study. Circulation 122, 790–797 (2010).

19. Myers, J. et al. Fitness versus physical activity patterns in predicting mortality in men. Am. J. Med. 117, 912–918 (2004).

20. Kodama, S. et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301, 2024–2035 (2009).

21. Berry, J. D. et al. Physical fitness and risk for heart failure and coronary artery disease. Circ. Heart Fail. 6, 627–634 (2013).

22. Pandey, A. et al. Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center longitudinal study. Am. Heart J. 169, 290–297.e1 (2015).

23. Howden, E. J. et al. Reversing the cardiac effects of sedentary aging in middle age — a randomized controlled trial: implications for heart failure prevention. Circulation 137, 1549–1560 (2018).

24. ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328, 189 (2004).

25. Lavie, C. J., Berra, K. & Arena, R. Formal cardiac rehabilitation and exercise training programs in heart failure: evidence for substantial clinical benefits. J. Cardiopulm. Rehabil. Prev. 33, 209–211 (2013).

26. Bhuva, A. N. et al. Training for a first-time marathon reverses age-related aortic stiffening. J. Am. Coll. Cardiol. 75, 60 (2020).

27. World Health Organization. Global Recommendations on Physical Activity for Health https://www.who.int/dietphysicalactivity/factsheet_recommendations/en/ (WHO, 2010).

28. Arem, H. et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern. Med. 175, 959–967 (2015).

29. Kyu, H. H. et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease study 2013. BMJ 354, i3857 (2016).

30. Schnohr, P., O’Keefe, J. H., Marott, J. L., Lange, P. & Jensen, G. B. Dose of jogging and long-term mortality: the Copenhagen City Heart Study. J. Am. Coll. Cardiol. 65, 411–419 (2015).

31. Lee, D.-C. et al. Leisure-time running reduces all-cause and cardiovascular mortality risk. J. Am. Coll. Cardiol. 64, 472–481 (2014).

32. Lee, D.-C., Lavie, C. J., Sui, X. & Blair, S. N. Running and mortality: is more actually worse? Mayo Clin. Proc. 91, 534–536 (2016).

33. Maron, B. J., Poliac, L. C. & Roberts, W. O. Risk for sudden cardiac death associated with marathon running. J. Am. Coll. Cardiol. 28, 428–431 (1996).

34. Harris, K. M., Henry, J. T., Rohman, E., Haas, T. S. & Maron, B. J. Sudden death during the triathlon. JAMA 303, 1255–1257 (2010).

35. Kim, J. H. et al. Cardiac arrest during long-distance running races. N. Engl. J. Med. 366, 130–140 (2012).

36. Finocchiaro, G. et al. Etiology of sudden death in sports: insights from a United Kingdom regional registry. J. Am. Coll. Cardiol. 67, 2108–2115 (2016).

37. Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M. & Mueller, F. O. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119, 1085–1092 (2009).

38. Corrado, D., Basso, C., Schiavon, M. & Thiene, G. Does sports activity enhance the risk of sudden cardiac death? J. Cardiovasc. Med. 7, 228–233 (2006).

39. Maron, B. J. et al. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 276, 199–204 (1996).

40. Harmon, K. G., Asif, I. M., Klossner, D. & Drezner, J. A. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 123, 1594–1600 (2011).

41. Eckart, R. E. et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J. Am. Coll. Cardiol. 58, 1254–1261 (2011).

42. Marijon, E. et al. Sudden cardiac arrest during sports activity in middle age. Circulation 131, 1384–1391 (2015).

43. Marijon, E. et al. Sports-related sudden death in the general population. Circulation 124, 672–681 (2011).

44. Chugh, S. S. & Weiss, J. B. Sudden cardiac death in the older athlete. J. Am. Coll. Cardiol. 65, 493–502 (2015).

45. Siscovick, D. S., Weiss, N. S., Fletcher, R. H. & Lasky, T. The incidence of primary cardiac arrest during vigorous exercise. N. Engl. J. Med. 311, 874–877 (1984).

46. Waller, B. F. & Roberts, W. C. Sudden death while running in conditioned runners aged 40 years or over. Am. J. Cardiol. 45, 1292–1300 (1980).

47. Mittleman, M. A. et al. Triggering of acute myocardial infarction by heavy physical exertion — protection against triggering by regular exertion. N. Engl. J. Med. 329, 1677–1683 (1993).

48. Albert, C. M. et al. Triggering of sudden death from cardiac causes by vigorous exertion. N. Engl. J. Med. 343, 1355–1361 (2000).

49. Sharma, S. et al. International recommendations for electrocardiographic interpretation in athletes. J. Am. Coll. Cardiol. 69, 1057–1075 (2017).

50. Maron, B. J. Structural features of the athlete heart as defined by echocardiography. J. Am. Coll. Cardiol. 7, 190–203 (1986).

51. Pelliccia, A., Culasso, F., Di Paolo, F. M. & Maron, B. J. Physiologic left ventricular cavity dilatation in elite athletes. Ann. Intern. Med. 130, 23–31 (1999).

52. Pelliccia, A., Maron, B. J., Spataro, A., Proschan, M. A. & Spirito, P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N. Engl. J. Med. 324, 295–301 (1991).

53. Scharhag, J. et al. Athlete’s heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J. Am. Coll. Cardiol. 40, 1856–1863 (2002).

54. Zaidi, A. et al. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation 127, 1783–1792 (2013).

55. Merghani, A. et al. Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation 136, 126–137 (2017).

56. Grimsmo, J., Grundvold, I., Maehlum, S. & Arnesen, H. Echocardiographic evaluation of aged male cross country skiers. Scand. J. Med. Sci. Sports 21, 412–419 (2011).

57. Lakatta, E. G. & Levy, D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 107, 346–354 (2003).

58. Hollingsworth, K. G., Blamire, A. M., Keavney, B. D. & Macgowan, G. A. Left ventricular torsion, energetics, and diastolic function in normal human aging. Am. J. Physiol. Heart Circ. Physiol. 302, H885–H892 (2012).

59. Oxenham, H. C. et al. Age-related changes in myocardial relaxation using three-dimensional tagged magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 5, 421–430 (2003).

60. Gledhill, N., Cox, D. & Jamnik, R. Endurance athletes’ stroke volume does not plateau: major advantage is diastolic function. Med. Sci. Sports Exerc. 26, 1116–1121 (1994).

61. Hieda, M. et al. Impact of lifelong exercise training dose on ventricular–arterial coupling. Circulation 138, 2638–2647 (2018).

62. Bhella, P. S. et al. Impact of lifelong exercise ‘dose’ on left ventricular compliance and distensibility. J. Am. Coll. Cardiol. 64, 1257–1266 (2014).

63. Chirinos, J. A. The run against arterial aging. J. Am. Coll. Cardiol. 75, 72–75 (2020).

64. Shibata, S. et al. The effect of lifelong exercise frequency on arterial stiffness. J. Physiol. 596, 2783–2795 (2018).

65. Pelliccia, A. et al. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 105, 944–949 (2002).

66. Benito, B. et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 123, 13–22 (2011).

67. Rao, Z., Wang, S., Bunner, W. P., Chang, Y. & Shi, R. Exercise induced right ventricular fibrosis is associated with myocardial damage and inflammation. Korean Circ. J. 48, 1014–1024 (2018).

68. Shave, R. et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J. Am. Coll. Cardiol. 56, 169–176 (2010).

69. Sharma, S., Papadakis, M. & Whyte, G. Chronic ultra-endurance exercise: implications in arrhythmogenic substrates in previously normal hearts. Heart 96, 1255–1256 (2010).

70. Aengevaeren, V. L. et al. Exercise-induced cardiac troponin I increase and incident mortality and cardiovascular events. Circulation 140, 804–814 (2019).

71. Neilan, T. G. et al. Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur. Heart J. 27, 1079–1084 (2006).

72. La Gerche, A., Connelly, K. A., Mooney, D. J., MacIsaac, A. I. & Prior, D. L. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart 94, 860–866 (2008).

73. Whyte, G. P. et al. Cardiac fatigue following prolonged endurance exercise of differing distances. Med. Sci. Sports Exerc. 32, 1067–1072 (2000).

74. Middleton, N. et al. Left ventricular function immediately following prolonged exercise: a meta-analysis. Med. Sci. Sports Exerc. 38, 681–687 (2006).

75. Douglas, P. S., O’Toole, M. L. & Woolard, J. Regional wall motion abnormalities after prolonged exercise in the normal left ventricle. Circulation 82, 2108–2114 (1990).

76. Niemelä, K. O., Palatsi, I. J., Ikäheimo, M. J., Takkunen, J. T. & Vuori, J. J. Evidence of impaired left ventricular performance after an uninterrupted competitive 24 hour run. Circulation 70, 350–356 (1984).

77. Utomi, V. et al. The impact of chronic endurance and resistance training upon the right ventricular phenotype in male athletes. Eur. J. Appl. Physiol. 115, 1673–1682 (2015).

78. D’Andrea, A. et al. Range of right heart measurements in top-level athletes: the training impact. Int. J. Cardiol. 164, 48–57 (2013).

79. Dávila-Román, V. G. et al. Transient right but not left ventricular dysfunction after strenuous exercise at high altitude. J. Am. Coll. Cardiol. 30, 468–473 (1997).

80. La Gerche, A. et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur. Heart J. 33, 998–1006 (2012).

81. Neilan, T. G. et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation 114, 2325–2333 (2006).

82. Urhausen, A., Scharhag, J., Herrmann, M. & Kindermann, W. Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events. Am. J. Cardiol. 94, 696–698 (2004).

83. Leetmaa, T. H., Dam, A., Glintborg, D. & Markenvard, J. D. Myocardial response to a triathlon in male athletes evaluated by Doppler tissue imaging and biochemical parameters. Scand. J. Med. Sci. Sports 18, 698–705 (2008).

84. Mousavi, N. et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am. J. Cardiol. 103, 1467–1472 (2009).

85. O’Hanlon, R. et al. Troponin release following endurance exercise: is inflammation the cause? A cardiovascular magnetic resonance study. J. Cardiovasc. Magn. Reson. 12, 38 (2010).

86. Gaudreault, V. et al. Transient myocardial tissue and function changes during a marathon in less fit marathon runners. Can. J. Cardiol. 29, 1269–1276 (2013).

87. La Gerche, A. et al. Disproportionate exercise load and remodeling of the athlete’s right ventricle. Med. Sci. Sports Exerc. 43, 974–981 (2011).

88. Heidbuchel, H. et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur. Heart J. 24, 1473–1480 (2003).

89. Ector, J. et al. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur. Heart J. 28, 345–353 (2007).

90. La Gerche, A. et al. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart 96, 1268–1274 (2010).

91. Sawant, A. C. et al. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. J. Am. Heart Assoc. 3, e001471 (2014).

92. Bohm, P. et al. Right and left ventricular function and mass in male elite master athletes: a controlled contrast-enhanced cardiovascular magnetic resonance study. Circulation 133, 1927–1935 (2016).

93. Kirchhof, P. et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114, 1799–1806 (2006).

94. Cruz, F. M. et al. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J. Am. Coll. Cardiol. 65, 1438–1450 (2015).

95. Ruwald, A.-C. et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 36, 1735–1743 (2015).

96. Saberniak, J. et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur. J. Heart Fail. 16, 1337–1344 (2014).

97. Pelliccia, A. et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the sport cardiology section of the European Association of Preventive Cardiology (EAPC). Eur. Heart J. 40, 19–33 (2019).

98. Lie, Ø. H. et al. Prediction of life-threatening ventricular arrhythmia in patients with arrhythmogenic cardiomyopathy: a primary prevention cohort study. JACC Cardiovasc. Imaging 11, 1377–1386 (2018).

99. Wilson, M. et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J. Appl. Physiol. 110, 1622–1626 (2011).

100. Breuckmann, F. et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 251, 50–57 (2009).

101. Tahir, E. et al. Myocardial fibrosis in competitive triathletes detected by contrast-enhanced CMR correlates with exercise-induced hypertension and competition history. JACC Cardiovasc. Imaging 11, 1260–1270 (2018).

102. van de Schoor, F. R. et al. Myocardial fibrosis in athletes. Mayo Clin. Proc. 91, 1617–1631 (2016).

103. Friedrich, M. G. et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J. Am. Coll. Cardiol. 53, 1475–1487 (2009).

104. Kwong, R. Y. et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113, 2733–2743 (2006).

105. Zorzi, A. et al. Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circ. Arrhythm. Electrophysiol. 9, e004229 (2016).

106. Schnell, F. et al. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie? Br. J. Sports Med. 50, 111–117 (2016).

107. Mitchell, J. D., Paisley, R., Moon, P., Novak, E. & Villines, T. C. Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke: the Walter Reed Cohort study. JACC Cardiovasc. Imaging 11, 1799–1806 (2018).

108. Bamberg, F. et al. Meta-analysis and systematic review of the long-term predictive value of assessment of coronary atherosclerosis by contrast-enhanced coronary computed tomography angiography. J. Am. Coll. Cardiol. 57, 2426–2436 (2011).

109. Möhlenkamp, S. et al. Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. J. Am. Coll. Cardiol. 57, 1455–1464 (2011).

110. Dores, H. et al. Subclinical coronary artery disease in veteran athletes: is a new preparticipation methodology required? Br. J. Sports Med. 54, 349–353 (2020).

111. Möhlenkamp, S. et al. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur. Heart J. 29, 1903–1910 (2008).

112. Braber, T. L. et al. Occult coronary artery disease in middle-aged sportsmen with a low cardiovascular risk score: the measuring athlete’s risk of cardiovascular events (MARC) study. Eur. J. Prev. Cardiol. 23, 1677–1684 (2016).

113. Aengevaeren, V. L. et al. Relationship between lifelong exercise volume and coronary atherosclerosis in athletes. Circulation 136, 138–148 (2017).

114. Franck, G. et al. Haemodynamic stress-induced breaches of the arterial intima trigger inflammation and drive atherogenesis. Eur. Heart J. 40, 928–937 (2019).

115. Libby, P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr. Rev. 65, 140–146 (2007).

116. Puri, R. et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J. Am. Coll. Cardiol. 65, 1273–1282 (2015).

117. Henein, M. et al. High dose and long-term statin therapy accelerate coronary artery calcification. Int. J. Cardiol. 184, 581–586 (2015).

118. Andelius, L., Mortensen, M. B., Nørgaard, B. L. & Abdulla, J. Impact of statin therapy on coronary plaque burden and composition assessed by coronary computed tomographic angiography: a systematic review and meta-analysis. Eur. Heart J. Cardiovasc. Imaging 19, 850–858 (2018).

119. Lee, S.-E. et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC Cardiovasc. Imaging 11, 1475–1484 (2018).

120. Adamson, P. D. & Newby, D. E. Non-invasive imaging of the coronary arteries. Eur. Heart J. 40, 2444–2454 (2019).

121. Radford, N. B. et al. Cardiorespiratory fitness, coronary artery calcium, and cardiovascular disease events in a cohort of generally healthy middle-age men. Circulation 137, 1888–1895 (2018).

122. DeFina, L. F. et al. Association of all-cause and cardiovascular mortality with high levels of physical activity and concurrent coronary artery calcification. JAMA Cardiol. 4, 174–181 (2019).

123. Pathak, R. K. et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J. Am. Coll. Cardiol. 66, 985–996 (2015).

124. Elosua, R. et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int. J. Cardiol. 108, 332–337 (2006).

125. Mohanty, S. et al. Differential association of exercise intensity with risk of atrial fibrillation in men and women: evidence from a meta-analysis. J. Cardiovasc. Electrophysiol. 27, 1021–1029 (2016).

126. Drca, N., Wolk, A., Jensen-Urstad, M. & Larsson, S. C. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart 100, 1037–1042 (2014).

127. Li, X., Cui, S., Xuan, D., Xuan, C. & Xu, D. Atrial fibrillation in athletes and general population: a systematic review and meta-analysis. Medicine 97, e13405 (2018).

128. Mont, L. et al. Long-lasting sport practice and lone atrial fibrillation. Eur. Heart J. 23, 477–482 (2002).

129. Baldesberger, S. et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur. Heart J. 29, 71–78 (2008).

130. Andersen, K. et al. Risk of arrhythmias in 52,755 long-distance cross-country skiers: a cohort study. Eur. Heart J. 34, 3624–3631 (2013).

131. Aizer, A. et al. Relation of vigorous exercise to risk of atrial fibrillation. Am. J. Cardiol. 103, 1572–1577 (2009).

132. Guasch, E. et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J. Am. Coll. Cardiol. 62, 68–77 (2013).

133. Molina, L. et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace 10, 618–623 (2008).

134. Iskandar, A., Mujtaba, M. T. & Thompson, P. D. Left atrium size in elite athletes. JACC Cardiovasc. Imaging 8, 753–762 (2015).

135. Mont, L. et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 10, 15–20 (2008).

136. Grimsmo, J., Grundvold, I., Maehlum, S. & Arnesen, H. High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors — a 28–30 years follow-up study. Eur. J. Cardiovasc. Prev. Rehabil. 17, 100–105 (2010).

137. Svedberg, N. et al. Long-term incidence of atrial fibrillation and stroke among cross-country skiers. Circulation 140, 910–920 (2019).

138. Zorzi, A. et al. Burden of ventricular arrhythmias at 12-lead 24-hour ambulatory ECG monitoring in middle-aged endurance athletes versus sedentary controls. Eur. J. Prev. Cardiol. 25, 2003–2011 (2018).

139. Zorzi, A. et al. Ventricular arrhythmias in young competitive athletes: prevalence, determinants, and underlying substrate. J. Am. Heart Assoc. 7, e009171 (2018).

140. Jensen-Urstad, K., Bouvier, F., Saltin, B. & Jensen-Urstad, M. High prevalence of arrhythmias in elderly male athletes with a lifelong history of regular strenuous exercise. Heart 79, 161–164 (1998).

141. Northcote, R. J., Canning, G. P. & Ballantyne, D. Electrocardiographic findings in male veteran endurance athletes. Br. Heart J. 61, 155–160 (1989).

142. D’Souza, A., Sharma, S. & Boyett, M. R. CrossTalk opposing view: bradycardia in the trained athlete is attributable to a downregulation of a pacemaker channel in the sinus node. J. Physiol. 593, 1749–1751 (2015).

143. Stein, R., Medeiros, C. M., Rosito, G. A., Zimerman, L. I. & Ribeiro, J. P. Intrinsic sinus and atrioventricular node electrophysiologic adaptations in endurance athletes. J. Am. Coll. Cardiol. 39, 1033–1038 (2002).

144. Ruiz, J. R., Morán, M., Arenas, J. & Lucia, A. Strenuous endurance exercise improves life expectancy: it’s in our genes. Br. J. Sports Med. 45, 159–161 (2011).

145. Sarna, S., Sahi, T., Koskenvuo, M. & Kaprio, J. Increased life expectancy of world class male athletes. Med. Sci. Sports Exerc. 25, 237–244 (1993).

146. Clarke, P. M. et al. Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era. Br. J. Sports Med. 49, 898–902 (2015).

147. Marijon, E. et al. Mortality of French participants in the Tour de France (1947–2012). Eur. Heart J. 34, 3145–3150 (2013).

148. Farahmand, B. Y. et al. Mortality amongst participants in Vasaloppet: a classical long-distance ski race in Sweden. J. Intern. Med. 253, 276–283 (2003).

149. Pelliccia, A., Maron, B. J., Culasso, F., Spataro, A. & Caselli, G. Athlete’s heart in women: echocardiographic characterization of highly trained elite female athletes. JAMA 276, 211–215 (1996).

150. Finocchiaro, G. et al. Effect of sex and sporting discipline on LV adaptation to exercise. JACC Cardiovasc. Imaging 10, 965–972 (2017).

151. Colombo, C. S. S. S. & Finocchiaro, G. The female athlete’s heart: facts and fallacies. Curr. Treat. Options Cardiovasc. Med. 20, 101–114 (2018).

152. Phillips, S. A., Mahmoud, A. M., Brown, M. D. & Haus, J. M. Exercise interventions and peripheral arterial function: implications for cardio-metabolic disease. Prog. Cardiovasc. Dis. 57, 521–534 (2015).